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Background: ERCP practically requires moderate to deep sedation controlled by a combination of benzodiazepine
and opiod. Propofol as a sole agent may cause oversedation. A combination (cocktail) of infused propofol,
meperidine, and midazolam can reduce the dosage of propofol and we hypothesized that it might decrease the
risk of oversedation. We prospectively compare the efficacy, recovery time, patient satisfactory, and side effects
between cocktail and conventional sedations in patients undergoing ERCP.
Methods: ERCP patients were randomized into 2 groups; the cocktail group (n = 103) and the controls (n = 102). For
induction, a combination of 25 mg of meperidine and 2.5 mg of midazolam were administered in both groups. In
the cocktail group, a bolus dose of propofol 1 mg/kg was administered and continuously infused. In the controls,
25 mg of meperidine or 2.5 mg/kg of midazolam were titrated to maintain the level of sedation.
Results: In the cocktail group, the average administration rate of propofol was 6.2 mg/kg/hr. In the control group;
average weight base dosage of meperidine and midazolam were 1.03 mg/kg and 0.12 mg/kg, respectively.
Recovery times and patients’ satisfaction scores in the cocktail and control groups were 9.67 minutes and
12.89 minutes (P= 0.045), 93.1and 87.6 (P <0.001), respectively. Desaturation rates in the cocktail and conventional
groups were 58.3% and 31.4% (P <0.001), respectively. All desaturations were corrected with temporary oxygen
supplementation without the need for scope removal.
Conclusions: Cocktail sedation containing propofol provides faster recovery time and better patients’ satisfaction
for patients undergoing ERCP. However, mild degree of desaturation may still develop.
Trial registration: ClinicalTrials.gov, NCT01540084
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In order to facilitate a high success rate and avoids
patients’ discomfort from a long procedure, endoscopic
retrograde cholangiopancreatography (ERCP) requires a
good moderate to deep level of sedation [1,2]. Propofol
has been increasingly used for sedation in many
gastrointestinal procedures including ERCP because it
has a shorter both half-life and results in a shorter re-
covery time than conventional sedation (opioid and/or* Correspondence: rungsun@pol.net
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distribution, and reproduction in any mediumbenzodiazepine)[3-6]. In addition, it can be safely admi-
nistered by non-anesthetist e.g. well-trained nurses with
or without endoscopist’s advice [7-9]. Because of its nar-
row therapeutic window, the level of conscious sedation
can easily go deeper from moderately deep sedation to
near general anesthesia. Therefore, propofol as a sole
agent can cause oversedation and apnea [4,10,11]. A
combination of benzodiazepine, and propofol has been
shown to reduce the dose requirement of propofol while
maintaining comparable efficacy [12,13]. This in turn
may reduce the risk of oversedation by propofol [14,15].
Moreover, at a moderate sedation level, propofol does not
have analgesic property, patients undergoing ERCP undered Central Ltd. This is an Open Access article distributed under the terms of
tp://creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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cocktail regimen containing meperidine/midazolam and
propofol may add additive analgesic effect during ERCP.
Furthermore, administering propofol by infusion pump
provides constant plasma level of propofol and may re-
duce adverse effect of overdosing by a bolus dose. How-
ever, data for cocktail sedation in ERCP is limited to only
a bolus propofol dosing [16,17].
This study was aimed to compare the differences in
terms of recovery time, patients’ satisfaction, and
sedation-related adverse events between conventional
sedation (meperidine and midazolam), and cocktail regi-
men (meperidine, midazolam and continuously infused
propofol) in patients undergoing ERCP.
Methods
Patients
Patients with suspected common bile duct stone(s) or
distal common bile duct obstruction scheduled for ERCP
during December 2006 to August 2009 at King Chula-
longkorn Memorial hospital were recruited. Patients
who were under 18 years old, pregnant; with American
Society of Anesthesiologists’ (ASA) physical classifica-
tion IV – V, with history of sulfite, egg or soy bean al-
lergy, with emergency need for ERCP, those who
informed consent could not be obtained, and those with
possible complex ERCP (hilar cholangiocarcinoma, post
Billroth II anatomy, etc. ) were excluded from this study.
Verbal and written informed consent was obtained from
all subjects. The randomization was done with a random
sequence generated by a computer. Concealed envelop
was broken when the patient was in the ERCP room.
ERCP procedures were performed by an experienced en-
doscopist who performed 300–400 ERCPs annually for
10 years. The patients were put in a prone position dur-
ing ERCP. The study protocol was approved by the Chu-
lalongkorn Medical Institutional Review Board.
Sedation and monitorings
During the procedure, patients’ conscious level, unex-
pected movement, blood pressure, heart rate and oxygen
saturation were monitored by an experienced endoscopy
nurse under supervision of an advanced endoscopy fel-
low who certified in advanced cardiopulmonary life sup-
port. Blood pressure was measured by an automated
blood pressure cuff every 5 minutes. Oxygen saturation
and heart rate were monitored by a pulse oxymetry ma-
chine. Respiratory effort and respiratory rate were
observed by visual inspection. All records were done at
baseline, just before starting sedation, and every five
minutes thereafter until patient had a full recovery.
When desaturation or apnea developed between the 5-
minute interval, those parameters were additionally
noted. Sedation was maintained at the level of moderate(purposeful response to verbal or tactile stimulation) to
deep sedation (purposeful response to repeated or pain-
ful stimulation)[1]. The oxygen supplementation was
given only when patients’ oxygen saturation dropped to
less than 90% and lasted for more than 10 seconds. Re-
suscitation equipments, flumazenil and naloxone were
available in the endoscopy unit.
After the procedure, patients were monitored for re-
covery scores (modified Aldrete score) [18]. Recovery
scores were calculated at every 15 minutes. Time to full
recovery was noted as the interval of 15 minutes. During
the first 15 min, a nurse monitored patient closely at
bedside and the exact time of full recovery in patients
with fast recovery was noted.
Outcome measurements and definitions
The nurses in the recovery room were blinded for type
of sedation. The procedure-related time included (1) in-
duction time (the time from sedation to scope intub-
ation), (2) procedural time (the time from scope
intubation to scope withdrawal), and (3) recovery time
(the time from scope withdrawal to full recovery (modi-
fied Aldrete score of 10)). The induction time and pro-
cedural time were recorded by the nurse in the
endoscopy unit. The recovery time was recorded by the
nurse in the recovery room.
Cardiopulmonary complications included (1) hypotension
(systolic blood pressure drops to less than 90 mmHg or
decreases more than 25% from the baseline), (2) bradycar-
dia (heart rate <50 beats/min), (3) desaturation (oxygen
saturation <90% for >10 seconds), and (4) apnea (cessa-
tion of respiratory activity for over 10 seconds under vis-
ual observation). If the oxygen saturation dropped to
<85% for more than 30 seconds despite oxygen supple-
mentation or apnea occurred, the procedure would be
interrupted and reversal medications would be given to
the patient.
Medications
Endoscopic nurse who well trained in propofol adminis-
tration, administered medications and continuously
monitored patients in both groups under supervision of
an advanced endoscopy fellow who certified in advanced
cardiac life support. All dosages were adopted from our
previous publication [6] and our previous experience in
using these agents. For induction, 25 mg of meperidine
and 2.5 mg of midazolam were administered in both
groups. In the cocktail group, one milligram per kilo-
gram body weight of 1% propofol emulsion (Baxter
Healthcare Corp., Irvine, CA) was slowly infused by an
automated pump (Terufusion syringe pump TE-331,
Terumo Corporation, Tokyo, Japan). To maintain con-
scious level of patient in the conventional group to be at
moderate or deep level, 25 mg of meperidine and/or
Table 1 Patient Characteristics
Conventional group Cocktail group P
Gender (male/female) 51/51 52/51 1.000
Age (years) a 57.27 ± 14.52 59.56 ± 13.65 0.246
Type of ERCP 0.877
- No-therapy* 17 (16.7%) 20 (18.4%)
- Therapy 83 (81.4%) 81 (78.6%)
- Fail 2 (1.9%) 2 (1.9%)
BMI a 22.18 ± 3.62 23.06 ± 3.83 0.097
ASA class 0.630
- I 42 (41.2%) 49 (47.6%)
- II 49 (48%) 43 (41.7%)
- III 11 (10.8%) 11 (10.7%)
a Data given as mean ± SD.
*No-therapy = cholangiogram and pancreatogram were obtained by contrast
injection and no treatment was required after the negative result of
cholangio-pancreatogram.






Mean dosage (mg) a N/A
- Meperidine 58.33 ± 24.46 25
- Midazolam 6.81 ± 2.12 2.5
- Propofol 0 172.08± 92.15
Dosage (mg/kg/hr) a N/A
- Meperidine 2.42 ± 2.58 1.06 ± 0.60
- Midazolam 0.29 ± 0.36 0.11 ± 0.06
- Propofol 0 6.18 ± 3.0
Indications for ERCP 0.621
- CBD stone 51 (50.0%) 53 (51.5%)
- Benign biliary stricture 7 (6.9%) 10 (9.7%)
- Malignant biliary stricture 28 (27.4%) 20 (19.4%)
- Pancreatic therapy 5 (4.9%) 8 (7.8%)
- Others 11 (10.8%) 12 (11.6)
Time to intubation (min) a 3.10 ± 1.86 3.68 ± 2.38 0.053
Duration (min) a 31.60 ± 17.56 27.88 ±14.38 0.099
a Data given as mean ± SD.
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whereas patients in the cocktail group were continuously
administered with 1% propofol at the rate of 1 mg/kg/hr.
An additional 0.5 mg/kg bolus was administered as
needed to achieve the designed conscious level.
Patient assessments
After patients gained a full level of consciousness, the in-
dependent nurse in recovery room who blinded to the
randomization assessed patients’ discomfort, gagging,
and satisfaction by using a visual analogue scale (VAS).
The VAS range from 0–100 for discomfort (0: none;100
worst discomfort imaginable, gagging (0: none; 100:
worst gagging imaginable), and satisfaction (0: not satis-
fied at all; 100: completely satisfied).
Statistical analysis
Sample sizes were calculated based on mean and stand-
ard deviation of recovery times in the convention groups
according to the results from our previous study;
34.25 minutes and 16.06, respectively [6]. To determine
the difference by two sided test with type I error of 0.05,
power of 85%, 20% reduction of recovery time, and the
ratio of study to control groups of 1, 100 subjects were
needed from each groups.
Continuous outcomes with normal distribution were
analyzed with independent 2 sample t-test, and Wil-
coxon sum rank test was used to analyze nonparametric
data. Categorical outcomes were analyzed with Chi-
square or Fisher’s exact test where appropriate. Reported
P value was 2-sided, with value of ≤ 0.05 considered sta-
tistically significant. The SPSS software version 16.0
(SPSS Inc., Chicago, IL, USA) was used to analyzed the
outcome.
Results
Patient and procedural variables
Two hundred and five patients were enrolled in the
study. One hundred and two patients and 103 patients
were randomly assigned into the conventional group
and the cocktail group respectively. The baseline charac-
teristics of patients including gender, age, type of ERCP,
body mass index (BMI) and ASA physical status classifi-
cation were not different (Table 1). The dosage of me-
peridine and midazolam in the conventional group were
2.42 and 0.29 mg/kg/hr, respectively, whereas the dosage
of meperidine, midazolam and propofol in the cocktail
group were 1.06, 0.11, and 6.18 mg/kg/hr, respectively.
Induction times in the convention group and the cock-
tail group were 3.10 and 3.68 minutes, respectively. Pro-
cedural times in the convention group and the cocktail
group were 31.60 and 27.88 minutes, respectively. These
results were not different between the two groups
(Table 2). Indications for ERCP and difficulty grade ofERCP were not different between the two groups
(Table 2).
Cardiovascular and respiratory parameters
Cardiovascular and respiratory data are shown in Table 3.
Baseline systolic blood pressure (SBP) in the convention
group and the cocktail group were 137.2 ± 22.1 and
134.2 ± 19.1 mmHg, respectively (p=0.309). Baseline
heart rate (HR) in the convention group and the cocktail
group were 86.0± 14.8 and 85.7± 15.1 beats/minute, re-
spectively (p=0.867). Baseline oxygen saturation (SpO2)
Table 3 Cardiovascular and respiratory parameters
Conventional group Cocktail group P
Baseline SBP (mmHg)a 137.2 ± 22.1 134.2 ± 19.1 0.309
Mean% decrease of SBPa from baseline 16.0 ± 10.5 17.2 ± 11.9 0.442
SBP decrease ≥25% from baseline (% of patients) 22.5 26.2 0.541
SBP <90 mmHg (% of patients) 4.9 13.6 0.057
Baseline heart rate (HR/min) a 86.0 ± 14.8 85.7 ± 15.1 0.867
Mean% decrease of HR from baseline a 12.5 ± 11.3 14.1 ± 12.3 0.333
HR decrease ≥25% from baseline (% of patients) 17.6 23.3 0.316
Bradycardia (% of patients) 0 1 1.000b
Apnea 0 0
Baseline SpO2 (%)
a 98.5 ± 1.5 97.8 ± 2.9 0.052
Greatest decline of SpO2 from baseline
a 6.7 ± 6.1 8.7 ± 6.9 0.026
SpO2 <90% (% of patients, any episodes) 31.4 58.3 <0.001
SpO2 <85% (% of patients, any episodes) 1.0 8.7 0.019b
a Data given as mean ± SD, b Fisher’s exact test.






Recovery time (min) 12.89 ± 12.87 9.67 ± 4.86 0.045
Conscious score at 15 min 9.73 ± 0.45 9.85 ± 0.53 0.102
Conscious score at 30 min 9.95 ± 0.21 9.99 ± 0.10 0.157
Conscious score at 45 min 9.99 ± 0.11 10.00 ± 0.00 0.320
Conscious score at 60 min 9.99 ± 0.11 10.00 ± 0.00 0.320
All data given as mean ± SD.
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98.5± 1.5 and 97.8± 2.9%, respectively (p=0.052). The
mean percentage of dropping in SBP in the convention
group and the cocktail group were 16.0 ± 10.5 and
17.2± 11.9%, respectively (p= 0.442). Percentage of
patients with SBP dropping more than 25% from the
baseline in the convention group and the cocktail group
were 22.5 and 26.5%, respectively (p=0.541). Five patients
(4.9%) in the convention group and 14 patients (13.6%) in
the cocktail group experienced hypotension, (p= 0.057).
One patient in the cocktail group experienced bradycar-
dia, which was transient and rescued by temporary cessa-
tion of propofol infusion, but the procedure was
successfully continued without interruption. Heart rate
decrease more than 25% from baseline developed in
17.6% and 23.3% of conventional and cocktail group, re-
spectively (p=0.316). Oxygen saturation of less than 90%
and 85% were found more in the cocktail group than in
the conventional group (58% vs. 31%; p < 0.001 and 9% vs.
1%; p=0.019, respectively). However, desturation episodes
were transient and all were corrected by patient arousal
with temporary oxygen supplement. No reversal medica-
tion was required and the procedure was interrupted
temporarily but no need for a scope withdrawal. After the
patient regained normal oxygen saturation level without
the need for oxygen supplement, the procedure was con-
tinued until finish. There was no apnea occurred in any
patients.
Recovery, patient tolerance and satisfaction
Recovery time, patients’ tolerance and satisfaction data are
shown in Tables 4 and 5. Mean recovery times in the
cocktail group and the conventional group were different
significantly (9.7 min vs. 12.9 min; p= 0.045). Conscious
score at 15, 30, 45 and 60 minutes were not differentbetween the two groups. There were significantly differ-
ences of discomfort and gagging between both groups
(p= 0.006 for discomfort and p=0.003 for gagging). Satis-
faction scores in the cocktail group and the conventional
group were 93.1 and 87.6 respectively, the difference was
also statistically significant (p< 0.001).
Discussion
Over the last decade, we have seen an increase in propo-
fol use for sedation in many GI endoscopies [2,3]. The
most important advantage of this agent is its fast recov-
ery profile. In addition, non-anesthetists are able to give
this agent. However, its narrow therapeutic window with
a possible risk of apnea is the main concern. Thus, ad-
equate experience of those who can administer this
agent and early detection of overdosing skill are
mandatory for patients’ safety. Propofol sedation at a
moderate level is safe and well accepted for many diag-
nostic GI procedures [1-3]. However, the risk will in-
crease if the level of conscious sedation is designed at
moderate to deep sedation. Practically, this level of sed-
ation is preferred for ERCP sedation. Our study con-
firmed the benefit of cocktail sedation containing
propofol infusion over the conventional sedation in






Discomfort (Median; inter-quartile) 10 (10, 20) 10 (0, 20) 0.006a
Gagging (Median; inter-quartile) 10 (10, 20) 10 (0, 20) 0.003a
Satisfaction 87.6 ± 9.6 93.1 ± 9.1 <0.001
a Mann–Whitney U test.
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tolerance, and satisfaction. Another hypothetical benefit
in the present study was decreasing the rate of desatur-
ation by reducing propofol dosage. We hypothesized
that by giving continuous perfusion of propofol, the con-
stant level of propofol would not exceed the therapeutic
window and this in turn might result in an acceptable
desaturation rate that comparable to the conventional
sedation. Although, the dosage of proposal used in this
study was lower than that of propofol infusion alone in
the same population reported by us previously (6.2 mg/
kg/hr vs. 9.4 mg.kg.hr) [6]. Unfortunately, the present
study failed to demonstrate the lower incidence of desat-
uration of this regimen over the conventional sedation.
We observed a higher percentage of desaturation in the
cocktail group than the conventional group (SpO2
<90%; 58.3% vs. 31.4%, p <0.01 and SpO2 < 85%; 8.7% vs.
1.0%, p < 0.019). However, these desaturation episodes
were very short and did not interfere the continuity of
our ERCP procedures. It may be implicated that redu-
cing the dose of propofol was not equivalent to decreas-
ing the risk of oversedation. We speculate that there are
some pitfalls in our study that require further investiga-
tion. First, prophylactic oxygen supplementation was not
routinely given to any of our patients. During the study
period, all desaturated patients recovered immediately
after oxygen cannula was given and only 2 L/min was
required. There was no need for assisted ventilation in any
patients. Other previous studies that gave a routine oxy-
gen supplementation showed a lower rate of desaturation
in the propofol group (5-24%) [12,13,17]. A prophylactic
oxygen supplementation may apply to prevent this adverse
event [19], however its discriminate use may expose
patients to delays in the diagnosis of disventilation by
maintaining apneic oxygenation during hypoventilation
[20]. Second, meperidine as the choice of narcotic agent
in this study may result in a higher rate of desaturation
than other short acting and milder narcotic agents such
as pentazocine and fentanyl. Pentazocine is a synthetic
narcotic that designed to have a lower rate of respiratory
suppression [21]. Ong, et al. used a combination of pent-
azocine and propofol for sedation in ERCP patients [17].
They demonstrated a lower rate of desaturation (<5%)
than ours. In addition, fentanyl is another narcotic with
shorter half-life than meperidine. When compared with
conventional sedation, a combination of propofol andfentanyl resulted in a faster recovery with similar safety
even when these combinations were given in cirrhotic
patients who underwent upper GI endoscopy [22]. Lastly,
hypercapnia usually develops before desaturation occurs
[23]. If we have used capnography in our study, we might
have detected earlier cases of propofol overdose and de-
saturation rate might have been lower. Qadeer, et al.
demonstrated that capnography is helpful for a better de-
tection of apnic episode when compared with visual re-
spiratory observation as confirmed by a lower hypoxic
rate in the patients who underwent ERCP/EUS with cap-
nography on board [24].
Cardiovascular adverse event related to propofol based
sedation is another concern in non-anesthetist adminis-
tered technique. Although, we observed a higher rate of
dropping in systolic blood pressure to less than
90 mmHg in the cocktail group than the conventional
group (14% vs. 5%), this rate of hypotension was not sta-
tistically significant and still comparable to the previous
studies (13%) [5,6]. Fortunately, these hypotensive epi-
sodes did not lead to any significant clinical cardiovascu-
lar compromise. We speculate that, histamine release
causing hypotension can occur after a rapid administra-
tion of meperidine [21]. Propofol itself can also cause
hypotesion by relaxing vascular smooth muscle [25].
Thus, the combined hypotensive effect may be potent
especially during the initial phase of sedation. Alterna-
tively, cocktail sedation containing fentanyl may cause a
lower rate of hypotensive effect since fentanyl does not
cause an over-release of histamine. However, further
comparison study is required to confirm this hypothesis.
One of the limitations is that the level of sedation on
each patient was controlled by a sedation nurse who was
unblinded to sedative agents. Perhaps, there might be a
bias in giving sedative agents at the doses that she pre-
ferred to be safe. However, this was more practical to real
life practice since the level of sedation must be adjusted to
the interest of patient safety as the first priority.
Although, we observed that the recovery time in the
present conventional group (12.89±12.87 minutes) seemed
to be shorter than previous studies including our previous
study (29–70 minutes) [4-6,10,25], the present study
showed that the recovery time in the cocktail group was
still significantly faster than the conventional group
(9.67±4.86 minutes vs. 12.89± 12.87 minutes, p=0.045).
We speculate that the overall shorter in procedural time
was because of only non-complex ERCP such as common
bile duct stone and distal common bile duct obstruction
were recruited in the study. The low level of complexity in
this seires was confirmed by a very low number of failed
ERCP in both groups (0-2%).
Our patients in the cocktail group reported a significant
higher satisfaction score than the patients in the conven-
tional group (93 vs. 88, p< 0.001). The result was in line
Angsuwatcharakon et al. BMC Anesthesiology 2012, 12:20 Page 6 of 7
http://www.biomedcentral.com/1471-2253/12/20with a study by Lee, et al. that showed a non-significantly
better satisfaction by patients when cocktail regimen was
used for ERCP [16]. Moreover, their study demonstrated a
significantly better satisfaction by both endoscopists /nurses
when propofol was used for sedation. During our study, we
did not encounter any undesirable movement that would
interfere the procedure outcome or delay the procedure
time of any of the patients from both groups. However, the
limitation in our study is that our protocol did not have a
formal intra-procedural assessment by sedation team.
Therefore, a complete evaluation of patients’ cooperation
may not be assessed from this study.
Conclusion
In conclusion, the present study shows the superiority of
cocktail sedation containing propofol infusion, midazo-
lam, and meperidine over conventional sedation in terms
of recovery profiles, patients’ tolerance, and satisfaction.
Although there was no serious adverse event in the
cocktail group, the results of the study actually showed
the cocktail sedation increased the rate of desaturation,
which implicated that reducing the dose of propofol in
this cocktail protocol was not equivalent to decreasing
the risk of oversedation. Adjustment in the protocol that
may overcome this problem is required. We propose on
using fentanyl or pentazocine instead of meperidine in
the regime. Lastly, a prophylactic oxygen supplementa-
tion and monitoring with capnography may be of help.
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